RETRACTED: Basic fibroblast growth factor accelerates matrix degradation via a neuro‐endocrine pathway in human adult articular chondrocytes
- 24 October 2007
- journal article
- retracted article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 215 (2) , 452-463
- https://doi.org/10.1002/jcp.21317
Abstract
Pain‐related neuropeptides released from synovial fibroblasts, such as substance P, have been implicated in joint destruction. Substance P‐induced inflammatory processes are mediated via signaling through a G‐protein‐coupled receptor, that is, neurokinin‐1 tachykinin receptor (NK1‐R). We determined the pathophysiological link between substance P and its receptor in human adult articular cartilage homeostasis. We further examined if catabolic growth factors such as basic fibroblast growth factor (bFGF or FGF‐2) or IL‐1β accelerate matrix degradation via a neural pathway upregulation of substance P and NK1‐R. We show here that substance P stimulates the production of cartilage‐degrading enzymes, such as matrix metalloproteinase‐13 (MMP‐13), and suppresses proteoglycan deposition in human adult articular chondrocytes via NK1‐R. Furthermore, we have demonstrated that substance P negates proteoglycan stimulation promoted by bone morphogenetic protein‐7, suggesting the dual role of substance P as both a pro‐catabolic and anti‐anabolic mediator of cartilage homeostasis. We report that bFGF‐mediated stimulation of substance P and its receptor NK1‐R is, in part, through an IL‐1β‐dependent pathway. J. Cell. Physiol. 215: 452–463, 2008.Keywords
This publication has 52 references indexed in Scilit:
- Basic Fibroblast Growth Factor Stimulates Matrix Metalloproteinase-13 via the Molecular Cross-talk between the Mitogen-activated Protein Kinases and Protein Kinase Cδ Pathways in Human Adult Articular ChondrocytesJournal of Biological Chemistry, 2007
- Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilageMatrix Biology, 2006
- Osteoarthritis: symptoms, signs and source of painInflammopharmacology, 2004
- Inhibitory Effects of Insulin-like Growth Factor-1 and Osteogenic Protein-1 on Fibronectin Fragment- and Interleukin-1β-stimulated Matrix Metalloproteinase-13 Expression in Human ChondrocytesJournal of Biological Chemistry, 2003
- Differential expression patterns of matrix metalloproteinases and their inhibitors during development of osteoarthritis in a transgenic mouse modelAnnals of the Rheumatic Diseases, 2002
- Prevalence of degenerative morphological changes in the joints of the lower extremityOsteoarthritis and Cartilage, 1997
- Inhibitory effects of basic fibroblast growth factor on chondrocyte differentiationJournal of Bone and Mineral Research, 1995
- Modulation of sulfated proteoglycan synthesis and collagen gene expression by chondrocytes grown in the presence of bFGF alone or combined with IGF1Reproduction Nutrition Développement, 1990
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986
- Elevated Levels of Tachykinin-like Immunoreactivity in Joint Fluids from Patients with Rheumatic Inflammatory DiseasesNew England Journal of Medicine, 1986